Business News • MarketWire • Imperial Capital, LLC Advises Atrium Innovations Inc. in Its $110 Million Acquisition of Dietary Supplement Marketer Seroyal International |
Imperial Capital, LLC Advises Atrium Innovations Inc. in Its $110 Million Acquisition of Dietary Supplement Marketer Seroyal International |
|
|
Imperial Capital, LLC Advises Atrium Innovations Inc. in Its $110 Million Acquisition of Dietary Supplement Marketer Seroyal International
LOS ANGELES, CA--(Marketwire - January 11, 2011) - Imperial Capital announced today that it acted as exclusive financial advisor to Atrium Innovations Inc. ("Atrium" or the "Company") in its $110 million acquisition of Seroyal International ("Seroyal"), a portfolio company of private equity firm Bruckmann, Rosser, & Sherrill & Co. Atrium is a recognized leading developer, manufacturer and marketer of professionally-endorsed, science-based dietary supplements for the health and nutrition industry. Based in Ontario, Seroyal is a premium dietary supplement company, which sells the Genestra, UNDA and Pharmax branded line of products through the healthcare practitioner channel ("HCP") in Canada and the U.S.
View More : http://www.marketwire.com/mw/release.do?id=1378277&sourceType=3
|
|
|